Xiaodong Zhang
Director of S&E Novartis AG
Xiaodong Zhang is in Business Development Search & Evaluation for Oncology and Hematology at Novartis, where she focuses on pipeline strategy and external innovation opportunities. She brings broad experience across strategy, R&D, commercialization, and business development, with deep expertise spanning U.S., China, and global markets. Prior to Novartis, she was a management consultant at McKinsey & Company, advising leading healthcare organizations on growth, portfolio strategy, and M&A. Xiaodong holds a PhD in Molecular and Cellular Biology from Harvard University and completed executive training at Harvard Business School.
Seminars
Take your seat across the table from pharma and VC leaders actively evaluating emerging platforms in this interactive roundtable setting. Understand their therapeutic interests and investment considerations, then showcase your pipeline and align on partnership expectations through rare face-to-face interactions to ignite interest in your pipeline and cultivate collaborative, strategic partnerships.
- Understand pharma and VC therapies of interest, considering in vivo and beyond to identify high-value opportunities
- For pharma and investors, engage with senior leaders from pioneering biotech and academics early to uncover opportunities for collaboration. • For biotech, gain actionable insights by hearing what your peers are developing and understanding first-hand the direction of pharma and biotech innovation
- Leave with new connections, strategic alignment opportunities, and practical knowledge to advance your projects
- Identifying the ideal development stage for engagement to ensure timely and effective collaboration
- Detailing therapies of interest, considering in vivo and beyond to identify high-value opportunities
- Discussing collaboration processes beyond initial interest to secure
